Enteral nutrition as treatment option for Crohn's disease: In kids only?

Nestle Nutrition Institute Workshop Series

Volumn 79, Issue , 2014, Pages 115-123

  Ruemmele, Frank M ^a   Pigneur, Bénédicte ^a   Garnier Lengliné, Hélène ^a  

^a Paris Diderot Sorbonne Cite University   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; CHILD; CROHN DISEASE; DIET THERAPY; ENTERIC FEEDING; HUMAN; META ANALYSIS (TOPIC); PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC); REMISSION; TREATMENT OUTCOME;

ADULT; CHILD; CROHN DISEASE; ENTERAL NUTRITION; HUMANS; META-ANALYSIS AS TOPIC; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REMISSION INDUCTION; TREATMENT OUTCOME;

EID: 84929501993     PISSN: 16642147     EISSN: 16642155     Source Type: Book Series    
DOI: 10.1159/000360716     Document Type: Conference Paper

References (43)

1. Xavier R, Podolsky D. Unravelling the pathogenesis of inflammatory bowel disease. Nature 2007; 448: 427-434
2. Knights D, Lassen KG, Xavier RJ. Advances in inflammatory bowel disease pathogenesis: linking host genetics and the microbiome. Gut 2013; 62: 1505-1510
3. Achkar JP, Fiocchi C. Gene-gene interactions in inflammatory bowel disease: biological and clinical implications. Am J Gastroenterol 2009; 104: 1734-1736
4. Franke A, McGovern DP, Barrett JC, et al. Genome-wide meta-Analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat Genet 2010; 42: 1118-1125
5. Jostins L, Ripke S, Weersma RK, et al. Hostmicrobe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 2012; 491: 119-124
6. Abraham C, Cho JH. Inflammatory bowel disease. N Engl J Med 2009; 361: 2066-2078
7. Rivas MA, Beaudoin M, Gardet A, et al. Deep resequencing of GWAS loci identifies independent rare variants associated with inflammatory bowel disease. Nat Genet 2011; 43: 1066-1073
8. Sandborn WJ, Feagan BG, Rutgeerts P, et al. Vedolizumab as induction and maintenance therapy for Crohn's disease. N Engl J Med 2013; 369: 711-721
9. Sandborn WJ, Colombel JF, Sands BE, et al. Abatacept for Crohn's disease and ulcerative colitis. Gastroenterology 2012; 14: 62-69
10. Colombel JF, Sandborn WJ, Reinisch W, et al. Infliximab, azathioprine, or combination therapy for Crohn's disease. N Engl J Med 2010; 362: 1383-1395
11. Lichtenstein GR, Feagan BG, Cohen RD, et al. Serious infection and mortality in patients with Crohn's disease: more than 5 years of follow-up in the TREAT TM registry. Am J Gastroenterol 2012; 107: 1409-1422
12. Beaugerie L, Brousse N, Bouvier AM, et al. Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study. Lancet 2009; 374: 1617-1625
13. Ruemmele FM, Roy CC, Levy E, Seidman EG. Nutrition as primary therapy in pediatric Crohn's disease: fact or fantasy? J Pediatr 2000; 136: 285-291
14. Johnson T, Macdonald S, Hill SM, et al. Treatment of active Crohn's disease in children using partial enteral nutrition with liquid formula: a randomised controlled trial. Gut 2006; 55: 356-361
15. Fell JM, Paintin M, Arnaud-Battandier F, et al. Mucosal healing and a fall in mucosal proinflammatory cytokine mRNA induced by a specific oral polymeric diet in pediatric Crohn's disease. Aliment Pharmacol Ther 2011; 33: 1332-1339
16. Heuschkel RB, Menache CC, Megerian JT, et al. Enteral nutrition and corticosteroids in the treatment of acute Crohn's disease in children. J Pediatr Gastroenterol Nutr 2000; 31: 8-15
17. Zachos M, Tondeur M, Griffiths AM. Enteral nutritional therapy for induction of remission in Crohn's disease. Cochrane Database Syst Rev 2007; 1: CD000542
18. Dziechciarz P, Horvath A, Shamir R, et al. Meta-Analysis: enteral nutrition in active Crohn's disease in children. Aliment Pharmacol Ther 2007; 26: 795-806
19. Seidman EG, Griffiths AM, Jones A, et al. Semi-elemental (S-E) diet versus prednisone in pediatric Crohn's disease. Gastroenterology 1994; 104: A778
20. Seidman EG, Lohoues MJ, Turgeon L, et al. Elemental diet versus prednisone as initial therapy in Crohn's disease: early and long term results. Gastroenterology 1991; 100: A250
21. Sanderson IR, Udeen S, Davies PS, et al. Remission induced by an elemental diet in small bowel Crohn's disease. Arch Dis Childhood 1987; 62: 123-127
22. Thomas AG, Taylor F, Miller V. Dietary intake and nutritional treatment in childhood Crohn's disease. J Pediatr Gastroenterol Nutr 1993; 17: 75-81
23. Ruuska T, Savilahti E, Maki M, et al. Exclusive whole protein enteral diet versus prednisolone in the treatment of acute Crohn's disease in children. J Pediatr Gastroenterol Nutr 1994; 19: 175-180
24. Griffiths AM, Pendley FC, Issenman RM. Elemental versus polymeric enteral nutrition as primary therapy for active Crohn's disease: a multi-centre pediatric randomized controlled trial. J Pediatr Gastroenterol Nutr 2000; 31: S75
25. Terrin G, Canani RB, Ambrosini A. A semielemental diet (Pregomin) as primary therapy for inducing remission in children with active Crohn's disease. Ital J Pediatr 2000; 28: 401-405
26. Borrelli O, Cordischi L, Cirulli M, et al. Polymeric diet alone versus corticosteroids in the treatment of active pediatric Crohn's disease: a randomized controlled open-label trial. Clin Gastroenterol Hepatol 2006; 4: 744-753
27. Akobeng AK, Miller V, Stanton J, et al. Double-blind randomized controlled trial of glutamine-enriched polymeric diet in the treatment of active Crohn's disease. J Pediatr Gastroenterol Nutr 2000; 30: 78-84
28. Ludvigsson JF, Krantz M, Bodin L, et al. Elemental versus polymeric enteral nutrition in paediatric Crohn's disease: a multicentre randomized controlled trial. Acta Paediatr 2004; 93: 327-335
29. Grogan JL, Casson DH, Terry A, et al. Enteral feeding therapy for newly diagnosed pediatric Crohn's disease: a double-blind randomized controlled trial with two years follow-up. Inflamm Bowel Dis 2012; 18: 246-253
30. Day AS, Whitten KE, Sidler M, et al. Systematic review: nutritional therapy in paediatric Crohns disease. Aliment Pharmacol Ther 2008; 27: 293-307
31. Wilson D, Thomas A, Croft N, et al. Systematic review of the evidence base for the medical treatment of paediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2010; 50(suppl 1): S14-S34
32. Rubio A, Pigneur B, Garnier-Lenglin H, et al. The efficacy of exclusive nutritional therapy in paediatric Crohn's disease, comparing fractionated oral vs continuous enteral feeding. Aliment Pharmacol Ther 2011; 33: 1322-1331
33. Buchanan E, Gaunt W, Cardigan T, et al. The use of exclusive enteral nutrition (EEN) for induction of remission in children with Crohn's disease (CD) demonstrates that disease phenotype does not influence clinical remission. Aliment Pharmacol Ther 2009; 30: 501-507
34. Verma S, Brown S, Kirkwood B, et al. Polymeric versus elemental diet as primary treatment in active Crohn's disease: a randomized, double-blind trial. Am J Gastroenterol 2000; 95: 735-739
35. Bannerjee K, Camacho-Hubner C, Babinska K, et al. Anti-inflammatory and growth-stimulating effects precede nutritional restitution during enteral feeding in Crohn disease. J Pediatr Gastroenterol Nutr 2004; 38: 270-275
36. Afzal NA, Van Der Zaag-Loonen HJ, Arnaud-Battandier F, et al. Improvement in quality of life of children with acute Crohn's disease does not parallel mucosal healing after treatment with exclusive enteral nutrition. Aliment Pharmacol Ther 2004; 20: 167-172
37. Berni CR, Terrin G, Borrelli O, et al. Shortand long-Term therapeutic efficacy of nutritional therapy and corticosteroids in paediatric Crohn's disease. Dig Liver Dis 2006; 38: 381-387
38. Beattie RM, Schiffrin EJ, Donnet-Hughes A, et al. Polymeric nutrition as the primary therapy in children with small bowel Crohn's disease. Aliment Pharmacol Ther 1994; 8: 609-615
39. Gerasimidis K, Nikolaou CK, Edwards CA, et al. Serial fecal calprotectin changes in children with Crohn's disease on treatment with exclusive enteral nutrition: associations with disease activity, treatment response, and prediction of a clinical relapse. J Clin Gastroenterol 2011; 45: 234-239
40. Afzal NA, Davies S, Paintin M, et al. Colonic Crohn's disease in children does not respond well to treatment with enteral nutrition if the ileum is not involved. Dig Dis Sci 2005; 50: 1471-1475
41. Lionetti P, Callegari ML, Ferrari S, et al. Enteral nutrition and microflora in pediatric Crohn's disease. J Parenter Enteral Nutr 2005; 29: S173-S175
42. Shiga H, Kajiura T, Shinozaki J, et al. Changes of faecal microbiota in patients with Crohn's disease treated with an elemental diet and total parenteral nutrition. Dig Liver Dis 2012; 44: 736-742
43. Pigneur B, Lepage P, Schmitz J, et al. Effect of exclusive enteral nutrition on the course of Crohn's disease and intestinal microbiota. JPGN 2013; 56(suppl 2): PA-G-0046